SMi is proud to present their 7th annual Pharmaceutical Parallel Trade Conference

Parallel trade 2013 aims to provide you with the latest developments from industry experts across a range of sectors. Parallel trade has shown to be a rapidly expanding – stay on top of the latest regulations and strategies of both traders and those who try who can take advantage of open trading.

Key reasons to attend include

• Hear from industry experts from both sides of the fence – how does this affect your company?

• Learn about market access and pricing strategies – how do traders affect drug access with big Pharma

• Parallel Trade 2013 is one of the only true events on this subject, develop your understanding in how traders affect patients

• Listen to industry experts on issues with counterfeiting of drugs and patient safety, what happens when open access is taken advantage of?

• Big pharma speakers will present on the effects of trading on R&D pipelines and intellectual property issues, when does patient access to drugs at a fair price begin to hinder future drugs being developed?

Keynote speakers include

• Jim Thomson, Chair, European Alliance for Access to Safe Medicines
• Heinz Kobelt, Director, EAEPC
• Janice Haigh, Practice leader, Market Access, Quintiles
• Antonio Alves, Director, MD Pharma
• Tomasz Dzitko, Direcor, Delfarma 
• Eric Noehrenberg, Director, Shire

PLUS TWO INTERACTIVE PRE CONFERENCE WORKSHOPS on 5th February 2013, Copthorne Tara, London:

A: Parallel Trade in Life Sciences
Workshop Leader: Nosh Lentin, Vice President, Operations & Supply Management
8.30am - 12.30pm

B: Parallel Trade Management Strategies
Workshop Leader: Jance Haigh, Practice Leader, Market Access, Quintiles
1.30pm - 5.30pm

For further information click here